Tryp Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
For the nine months, net loss was CAD 3.58 million compared to CAD 5.33 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | +9.09% | +50.00% |
Mar. 08 | Tryp Therapeutics Inc. announced that it has received AUD 3.39 million in funding | CI |
Feb. 05 | Tryp Therapeutics Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+50.00% | 4.23M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |